News Focus
News Focus
icon url

runncoach

05/22/19 5:33 PM

#10749 RE: Biostudent #10748

100% agree Bio and have stated the same months back. I have no idea if they start one or not before hand. I've had suspicions that maybe they were waiting for an oral version before Fragile X which would be huge but that's just a guess. Truth is when a childrens'hospital agrees run a trial like this for you for 200k, you be patient and wait til they fit you in. I fully expect hero or zero for the AD trial this summer.

Same happened for AXSM. Once they got the top line results, then they put out the other indications as they raised money. Share price up another 3 bucks since I mentioned them a couple days back and moving closer to a billion market cap. Best comparison to us I can come up with.
icon url

XenaLives

05/22/19 6:11 PM

#10752 RE: Biostudent #10748

Can't recall, was there any third party support for Fragile X or MS, or was it just spin?

icon url

rayovacAAA

05/23/19 2:49 PM

#10761 RE: Biostudent #10748

No need to worry, Dr. Alkon said "look at the data".


Hero or zero based on 16 patients is the correct characterization, no wonder they won't start additional trials.